TGFB1 and neoplasm: In the tumor microenvironment, TGF-β, IL-10, and IL-6 suppress NK cell activity and affect immunosuppressive cells and pro-inflammatory cytokines, decreasing the antitumor response of NK cells and promoting subsequent tumor evasion and progression [1].